PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro.

about

PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro.

Item

http://www.wikidata.org/entity/Q43658240

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

PET should replace SPECT in ca ...... h known or suspected CAD: Pro.

@en

PET should replace SPECT in ca ...... h known or suspected CAD: Pro.

@nl

type

Item

label

PET should replace SPECT in ca ...... h known or suspected CAD: Pro.

@en

PET should replace SPECT in ca ...... h known or suspected CAD: Pro.

@nl

prefLabel

PET should replace SPECT in ca ...... h known or suspected CAD: Pro.

@en

PET should replace SPECT in ca ...... h known or suspected CAD: Pro.

@nl

P1476

PET should replace SPECT in ca ...... th known or suspected CAD: Pro

@en

P2093

Jamshid Maddahi

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac PET perfusion: prognosis, risk stratification, and clinical management

Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease

Effects of radiation exposure from cardiac imaging: how good are the data?

Properties of an ideal PET perfusion tracer: new PET tracer cases and data.

Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis.

Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET

Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.

Cardiac PET perfusion tracers: current status and future directions.

P2888

s12350-015-0300-7

P304

1955-1959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12350-015-0300-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rene Packard

P577

2017-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084774453

http://www.w3.org/2001/XMLSchema#string

P698

28397181

http://www.w3.org/2001/XMLSchema#string